• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为慢性心力衰竭患者住院时间和再入院预测指标的研究洞察

Insights into the Neutrophil-to-Lymphocyte Ratio and the Platelet-to-Lymphocyte Ratio as Predictors for the Length of Stay and Readmission in Chronic Heart Failure Patients.

作者信息

Cristescu Liviu, Tilea Ioan, Iancu Dragos-Gabriel, Stoica Florin, Moldovan Diana-Andreea, Capriglione Vincenzo, Varga Andreea

机构信息

Faculty of Medicine in English, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.

Doctoral School, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.

出版信息

Diagnostics (Basel). 2024 Sep 23;14(18):2102. doi: 10.3390/diagnostics14182102.

DOI:10.3390/diagnostics14182102
PMID:39335781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11431337/
Abstract

UNLABELLED

Chronic heart failure (CHF) is characterized by complex pathophysiology, leading to increased hospitalizations and mortality. Inflammatory biomarkers such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) provide valuable diagnostic insights.

METHODS

This study evaluates the prognostic relationship between NLR, PLR, and, in a specific subcohort, N-terminal pro B-type natriuretic peptide (NT-proBNP), alongside length of stay (LOS) and 90-day readmission rates in CHF patients, irrespective of heart failure phenotype. A retrospective analysis of 427 CHF admissions (males = 57.84%) was conducted.

RESULTS

The mean age of the entire population was 68.48 ± 11.53 years. The average LOS was 8.33 ± 5.26 days, with a readmission rate of 73 visits (17.09%) for 56 patients. The NLR (3.79 ± 3.32) showed a low but positive correlation with the LOS (r = 0.222, < 0.001). Conversely, the PLR (144.84 ± 83.08) did not demonstrate a significant association with the LOS. The NLR presented a low negative correlation for days until the next admission (r = -0.023, = 0.048). In a prespecified subanalysis of 323 admissions, the NT-proBNP exhibited a low positive Pearson correlation with the NLR (r = 0.241, < 0.001) and PLR (r = 0.151, = 0.006).

CONCLUSIONS

The impact of the NLR across heart failure phenotypes may suggest the role of systemic inflammation in understanding and managing CHF.

摘要

未标注

慢性心力衰竭(CHF)具有复杂的病理生理学特征,导致住院率和死亡率增加。中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)等炎症生物标志物提供了有价值的诊断见解。

方法

本研究评估了NLR、PLR以及在特定亚组中N末端B型利钠肽原(NT-proBNP)与CHF患者住院时间(LOS)和90天再入院率之间的预后关系,而不考虑心力衰竭表型。对427例CHF住院患者(男性占57.84%)进行了回顾性分析。

结果

整个人口的平均年龄为68.48±11.53岁。平均住院时间为8.33±5.26天,56例患者的再入院率为73次(17.09%)。NLR(3.79±3.32)与住院时间呈低但正相关(r = 0.222,<0.001)。相反,PLR(144.84±83.08)与住院时间未显示出显著关联。NLR与下次入院前天数呈低负相关(r = -0.023,= 0.048)。在对323例住院患者的预先指定亚分析中,NT-proBNP与NLR(r = 0.241,<0.001)和PLR(r = 0.151,= 0.006)呈低正Pearson相关性。

结论

NLR对心力衰竭各表型的影响可能提示全身炎症在理解和管理CHF中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/32f28129e1f4/diagnostics-14-02102-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/28ae14e33a87/diagnostics-14-02102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/d672fb3efcc0/diagnostics-14-02102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/5f61f54044f9/diagnostics-14-02102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/c3a7966b6c5f/diagnostics-14-02102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/254c58ecf3ee/diagnostics-14-02102-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/32f28129e1f4/diagnostics-14-02102-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/28ae14e33a87/diagnostics-14-02102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/d672fb3efcc0/diagnostics-14-02102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/5f61f54044f9/diagnostics-14-02102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/c3a7966b6c5f/diagnostics-14-02102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/254c58ecf3ee/diagnostics-14-02102-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1526/11431337/32f28129e1f4/diagnostics-14-02102-g006.jpg

相似文献

1
Insights into the Neutrophil-to-Lymphocyte Ratio and the Platelet-to-Lymphocyte Ratio as Predictors for the Length of Stay and Readmission in Chronic Heart Failure Patients.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为慢性心力衰竭患者住院时间和再入院预测指标的研究洞察
Diagnostics (Basel). 2024 Sep 23;14(18):2102. doi: 10.3390/diagnostics14182102.
2
Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure.优化循环生物标志物组合作为 COPD 急性加重期合并心力衰竭患者预后的预测指标。
Int J Med Sci. 2021 Feb 4;18(7):1592-1599. doi: 10.7150/ijms.52405. eCollection 2021.
3
A Retrospective Study of Admission NT-proBNP Levels as a Predictor of Readmission Rate, Length of Stay and Mortality.一项关于入院时NT-proBNP水平作为再入院率、住院时间和死亡率预测指标的回顾性研究。
HCA Healthc J Med. 2021 Jun 28;2(3):207-214. doi: 10.36518/2689-0216.1143. eCollection 2021.
4
Are Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios Prognostic Indicators in Patients With Chronic Obstructive Pulmonary Disease in Intensive Care Units?中性粒细胞与淋巴细胞、血小板与淋巴细胞以及单核细胞与淋巴细胞比值是重症监护病房中慢性阻塞性肺疾病患者的预后指标吗?
Cureus. 2022 Mar 26;14(3):e23499. doi: 10.7759/cureus.23499. eCollection 2022 Mar.
5
Correlation Between Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Risk Stratification Indicators and Thrombus Burden in Patients with Moderate-to-High Risk Acute Pulmonary Embolism, and Changes After Treatment.中高危急性肺栓塞患者中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值与危险分层指标及血栓负荷的相关性以及治疗后的变化
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241285446. doi: 10.1177/10760296241285446.
6
Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和嗜酸性粒细胞与淋巴细胞比值(ELR)作为慢性阻塞性肺疾病急性加重(AECOPD)患者的生物标志物。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 23;19:501-518. doi: 10.2147/COPD.S447519. eCollection 2024.
7
Correlation of Hemoglobin Level With New Inflammatory Markers in the Emergency Department: A Retrospective Study Exploring Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte, and Mean Platelet Volume-to-Platelet Count Ratios.急诊科血红蛋白水平与新炎症标志物的相关性:一项探索中性粒细胞与淋巴细胞、单核细胞与淋巴细胞、血小板与淋巴细胞以及平均血小板体积与血小板计数比值的回顾性研究。
Cureus. 2024 Mar 2;16(3):e55401. doi: 10.7759/cureus.55401. eCollection 2024 Mar.
8
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值是心力衰竭的预测指标。
Arq Bras Cardiol. 2015 Dec;105(6):606-13. doi: 10.5935/abc.20150126. Epub 2015 Nov 3.
9
Association between neutrophil percentage-to-albumin ratio (NPAR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and long-term mortality in community-dwelling adults with heart failure: evidence from US NHANES 2005-2016.中性粒细胞百分比与白蛋白比值(NPAR)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)与心力衰竭社区居民长期死亡率的关系:来自美国 NHANES 2005-2016 年的证据。
BMC Cardiovasc Disord. 2023 Jun 21;23(1):312. doi: 10.1186/s12872-023-03316-6.
10
Postpartum Depression and Inflammatory Biomarkers of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio: A Prospective Observational Study.产后抑郁症与中性粒细胞-淋巴细胞比值、血小板-淋巴细胞比值和单核细胞-淋巴细胞比值的炎症生物标志物:一项前瞻性观察研究。
Gynecol Obstet Invest. 2024;89(2):140-149. doi: 10.1159/000536559. Epub 2024 Feb 12.

引用本文的文献

1
Exploring the Platelet-to-Lymphocyte Ratio for Risk Stratification in Heart Failure: A Systematic Review.探索血小板与淋巴细胞比值在心力衰竭风险分层中的应用:一项系统评价
Cureus. 2025 Aug 6;17(8):e89522. doi: 10.7759/cureus.89522. eCollection 2025 Aug.
2
Impact of the hemoglobin-to-red cell distribution width ratio on 30-day readmission in patients with heart failure.血红蛋白与红细胞分布宽度比值对心力衰竭患者30天再入院率的影响。
BMC Cardiovasc Disord. 2025 Mar 25;25(1):219. doi: 10.1186/s12872-025-04673-0.
3
Proposed Novel Heart Failure Biomarkers and Their Association with Length of Hospital Stay and Mortality: A Retrospective Observational Pilot Study.

本文引用的文献

1
Application of neutrophil-lymphocyte ratio and red blood cell distribution width in diabetes mellitus complicated with heart failure.中性粒细胞与淋巴细胞比值及红细胞分布宽度在糖尿病合并心力衰竭中的应用
World J Diabetes. 2024 Jun 15;15(6):1226-1233. doi: 10.4239/wjd.v15.i6.1226.
2
Association between blood inflammatory indices and heart failure: a cross-sectional study of NHANES 2009-2018.血液炎症指标与心力衰竭之间的关联:一项针对2009 - 2018年美国国家健康与营养检查调查(NHANES)的横断面研究。
Acta Cardiol. 2024 Jun;79(4):473-485. doi: 10.1080/00015385.2024.2356325. Epub 2024 May 21.
3
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Acute Decompensated Heart Failure: A Meta-Analysis.
新型心力衰竭生物标志物及其与住院时间和死亡率的关联:一项回顾性观察性初步研究。
Diagnostics (Basel). 2025 Feb 28;15(5):589. doi: 10.3390/diagnostics15050589.
4
The systemic inflammation response index as risks factor for all-cause and cardiovascular mortality among individuals with respiratory sarcopenia.全身炎症反应指数作为呼吸性肌肉减少症患者全因死亡和心血管死亡的危险因素。
BMC Pulm Med. 2025 Feb 26;25(1):90. doi: 10.1186/s12890-025-03525-z.
5
The Effects of Beta-Blockers on Leukocytes and the Leukocyte Subpopulation in Heart Failure Patients.β受体阻滞剂对心力衰竭患者白细胞及白细胞亚群的影响
Biomedicines. 2024 Dec 20;12(12):2907. doi: 10.3390/biomedicines12122907.
中性粒细胞与淋巴细胞比值在急性失代偿性心力衰竭患者中的预后价值:一项荟萃分析
J Clin Med. 2024 Feb 21;13(5):1212. doi: 10.3390/jcm13051212.
4
The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension.中性粒细胞与淋巴细胞比值与高血压患者的全因死亡率和心血管死亡率相关。
Cardiovasc Diabetol. 2024 Apr 2;23(1):117. doi: 10.1186/s12933-024-02191-5.
5
Neutrophil-to-lymphocyte ratio (NLR) predicts mortality in hospitalized geriatric patients independent of the admission diagnosis: a multicenter prospective cohort study.中性粒细胞与淋巴细胞比值(NLR)可独立于入院诊断预测住院老年患者的死亡率:一项多中心前瞻性队列研究。
J Transl Med. 2023 Nov 21;21(1):835. doi: 10.1186/s12967-023-04717-z.
6
Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值(NLR)对心力衰竭预后的影响:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2023 Nov 14;23(1):555. doi: 10.1186/s12872-023-03572-6.
7
Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness.中性粒细胞与淋巴细胞比值作为炎症生物标志物及心力衰竭、心血管疾病和慢性炎症性疾病的预后标志物:预测抗细胞因子治疗反应性的潜在指标的新见解。
Microvasc Res. 2023 Nov;150:104598. doi: 10.1016/j.mvr.2023.104598. Epub 2023 Aug 24.
8
The Value of Neutrophil-to-Lymphocyte Ratio and Epicardial Adipose Tissue Thickness in Heart Failure With Preserved Ejection Fraction.中性粒细胞与淋巴细胞比值及心外膜脂肪组织厚度在射血分数保留的心力衰竭中的价值
Cureus. 2023 Aug 2;15(8):e42846. doi: 10.7759/cureus.42846. eCollection 2023 Aug.
9
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as new possible minor criteria for diagnosis of polycythemia vera.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值作为真性红细胞增多症诊断的新的可能的次要标准。
Int J Lab Hematol. 2023 Dec;45(6):853-859. doi: 10.1111/ijlh.14138. Epub 2023 Jul 27.
10
Association between neutrophil percentage-to-albumin ratio (NPAR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and long-term mortality in community-dwelling adults with heart failure: evidence from US NHANES 2005-2016.中性粒细胞百分比与白蛋白比值(NPAR)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)与心力衰竭社区居民长期死亡率的关系:来自美国 NHANES 2005-2016 年的证据。
BMC Cardiovasc Disord. 2023 Jun 21;23(1):312. doi: 10.1186/s12872-023-03316-6.